同仁堂：公司产品麻仁润肠丸获得加拿大产品许可证

Core Viewpoint - Tongrentang (600085.SH) has received a product license from the Canadian Ministry of Health for its product, Ma Ren Run Chang Wan, indicating a step towards potential market entry in Canada [1] Group 1: Regulatory Approval - The product license granted is categorized as a Class III product license, which is significant for the company's expansion plans [1] - The approval allows Tongrentang Pharmaceutical Factory to register its product in Canada, although further administrative approvals are required for market sales [1] Group 2: Impact on Financial Performance - The company stated that this approval will not have a significant impact on its recent operating performance [1]